Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer

Breast Cancer Research and Treatment

Volumn 152, Issue 1, 2015, Pages 209-216

  Rose, Brent S ^a   Jiang, Wei ^b   Punglia, Rinaa S ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Breast cancer specific survival; Lymph node metastasis size; SEER

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; TUMOR VOLUME; BREAST NEOPLASMS; MORTALITY; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; YOUNG ADULT;

EID: 84931009113     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3451-y     Document Type: Article

References (23)

1. Fisher B, Ravdin RG, Ausman RK et al (1968) Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg 168:337–356
2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716
3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127–2135
4. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK (1999) Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17:2334–2340
5. Fisher B, Bauer M, Wickerham DL et al (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52:1551–1557
6. Attiyeh FF, Jensen M, Huvos AG, Fracchia A (1977) Axillary micrometastasis and macrometastasis in carcinoma of the breast. Surg Gynecol Obstet 144:839–842
7. Fisher ER, Palekar A, Rockette H, Redmond C, Fisher B (1978) Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer 42:2032–2038
8. Rosen PP, Saigo PE, Braun DW et al (1981) Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg 194:585–591
9. Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119
10. Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66
11. Mittendorf EA, Hunt KK, Boughey JC et al (2012) Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255:109–115
12. Harris EE, Freilich J, Lin HY, Chuong M, Acs G (2013) The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1–3 positive axillary nodes after mastectomy. Int J Radiat Oncol Biol Phys 85:609–614
13. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973–2008) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2011. http://www.seer.cancer.gov. Accessed 1 Aug 2014
14. Edge SB, Byrd DR, Compton CC et al (eds) (2010) Breast in AJCC cancer staging manual, 7th edn. New York, Springer, pp 347–376
15. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
16. Kim J, Yoo SW, Kang SR et al (2012) Prognostic significance of metabolic tumor volume measured by (18)F-FDG PET/CT in operable primary breast cancer. Nucl Med Mol Imaging 46:278–285
17. Song BI, Lee SW, Jeong SY et al (2012) 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer. J Nucl Med 53:1337–1344
18. Crabb SJ, Cheang MC, Leung S et al (2008) Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer 8:249–256
19. Van Calster B, Vanden Bempt I, Drijkoningen M et al (2009) Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat 113:181–187
20. Fisher BJ, Perera FE, Cooke AL et al (1997) Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Int J Radiat Oncol Biol Phys 38:551–559
21. Neri A, Marrelli D, Roviello F et al (2005) Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer. Ann Surg Oncol 2005(12):246–253
22. Hetelekidis S, Schnitt SJ, Silver B et al (2000) The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys 46:31–34
23. Gruber G, Cole BF, Castiglione-Gertsch M et al (2008) Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol 19:1393–1401